Literature DB >> 21451473

Hypertension: new meta-analysis shows no cancer risk with angiotensin-receptor blockers.

Bryony M Mearns.   

Abstract

Entities:  

Year:  2011        PMID： 21451473     DOI： 10.1038/nrcardio.2011.41

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

Review 1.  Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.

Authors: 
Journal:  J Hypertens       Date:  2011-04       Impact factor: 4.844
  1 in total
  2 in total

1.  Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis.

Authors:  Ahmed Alhusban; Ahmad Al-Azayzih; Anna Goc; Fei Gao; Susan C Fagan; Payaningal R Somanath
Journal:  J Pharmacol Exp Ther       Date:  2014-07-02       Impact factor: 4.030

2.  Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer.

Authors:  Danial Mehranfard; Gabriela Perez; Andres Rodriguez; Julia M Ladna; Christopher T Neagra; Benjamin Goldstein; Timothy Carroll; Alice Tran; Malav Trivedi; Robert C Speth
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-07-05       Impact factor: 1.636
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.